Axcella Health/AXLA
$0.40
-8.89%-
1D1W1MYTD1YMAX
About Axcella Health
Axcella Health Inc. is a clinical-stage biotechnology company. The Company is focused on a new approach to treat complex diseases using compositions of endogenous metabolic modulators (EMMs). Its product candidates are comprised of multiple EMMs that are engineered in distinct combinations and ratios with simultaneously impacting multiple biological pathways. Its pipeline includes lead therapeutic candidates for the treatment of Long COVID (also known as Post-COVID-19 Condition and Post-Acute Sequelae of COVID-19 (PASC)) associated fatigue, and the treatment of non-alcoholic steatohepatitis (NASH). AXA1665 is a product candidate for the reduction in risk of Overt Hepatic Encephalopathy (OHE) recurrence in adult patients with liver cirrhosis. AXA1125 is also being developed as a product candidate for the treatment of Long COVID. AXA1125 is an oral product candidate for the treatment of NASH. AXA1125 is an oral product candidate that contains six amino acids and derivatives.
Ticker
AXLA
Sector
Healthcare
Trading on
OTC
Industry
Biotechnology & Drugs
CEO
Craig Jalbert
Employees
11
Headquarters
Cambridge, United States
Website
axcellatx.com
Axcella Health Metrics
BasicAdvanced
$14M
Market cap
-
P/E ratio
-$19.12
EPS
0.91
Beta
-
Dividend rate
Price and volume
Market cap
$14M
Beta
0.91047
52-week high
$41.25
52-week low
$2.59
Average daily volume
959K
Financial strength
Current ratio
0.803
Interest coverage (TTM)
-47.46%
Management effectiveness
Return on assets (TTM)
-162.77%
Return on equity (TTM)
-1,370.17%
Return on investment (TTM)
-315.8%
Valuation
Growth
Earnings per share change (TTM)
55.88%
What the Analysts think about Axcella Health
Analyst Ratings
Majority rating from 2 analysts.
Price Targets
Average projection from 2 analysts.
High $375.00
Low $10.53
$0.40
Current price
$192.77
Average price target
Axcella Health Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q2 23
QoQ growth
Revenue
$0
NaN%
Net income
-$3.4M
-12.82%
Profit margin
0%
NaN%
Axcella Health Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q3 22
Q4 22
Q1 23
Q2 23
Q3 23
Actual
-$0.34
-$0.33
-$0.05
-$0.05
-
Expected
-$0.38
-$0.30
-$0.16
-$0.06
-$1.25
Surprise
-10.92%
10%
-68.75%
-16.67%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Upcoming events
FAQs
What’s the current market cap for Axcella Health stock?
Axcella Health (AXLA) has a market cap of $14M as of May 15, 2024.
What is the P/E ratio for Axcella Health stock?
The price to earnings (P/E) ratio for Axcella Health (AXLA) stock is 0 as of May 15, 2024.
Does Axcella Health stock pay dividends?
No, Axcella Health (AXLA) stock does not pay dividends to its shareholders as of May 15, 2024.
When is the next Axcella Health dividend payment date?
Axcella Health (AXLA) stock does not pay dividends to its shareholders.
What is the beta indicator for Axcella Health?
Axcella Health (AXLA) has a beta rating of 0.91. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
What is the Axcella Health stock price target?
The target price for Axcella Health (AXLA) stock is $192.77, which is 48092.5% above the current price of $0.4. This is an average based on projections from 2 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.
Buy or sell Axcella Health stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.